|
| Gene | Expression | Site | Net effect |
|
| glucose-6-phosphatase [5] | Increase | liver | Increase gluconeogenesis and glycogenolysis |
| protein kinase B (Akt2) [5] | decrease | liver | Decrease glycogen synthesis |
| β2-adrenergic receptor [5] | Increase | liver | Increase gluconeogenesis and glycogenolysis |
| inhibitory G protein (Gi) [5] | decrease | liver | Increase gluconeogenesis and glycogenolysis |
| phosphoenolpyruvate carboxykinase (PEPCK) [6] | Increase | liver | Increase gluconeogenesis |
| pyruvate carboxylase (PC) [7] | Increase | liver | Increase gluconeogenesis |
| GLUT2 [8] | Increase | liver | Increase glucose output |
| malic enzyme [10] | Increase | liver | lipogenesis |
| Carbohydrate-response element-binding protein (ChREBP) [12] | Increase | liver and fat tissue | lipogenesis |
| GLUT1 [14] | Increase | peripheral tissues | Increase glucose transport (basal) |
| GLUT4 [14] | Increase | peripheral tissues | Increase glucose transport (insulin-induced) |
| β2-adrenergic receptor [20] | Increase | Peripheral tissues | Increase lipolysis |
| phosphoglycerate kinase (PGK) [15] | Increase | peripheral tissues | Increase glycolysis |
| Hypoxia-inducible factor 1 (HIF-1α) [15] | Increase | peripheral tissues | Increase glycolysis |
| PPAR gamma coactivator-1 alpha (PGC-1 alpha) [27] | Increase | peripheral tissues | Increase mitochondrial biogenesis and function |
| uncoupling protein 3 (UCP3) [17] | Increase | peripheral tissues | Increase mitochondrial energy expenditure |
|